Research Paper Volume 15, Issue 13 pp 6526—6544
N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer
Figure 3. Representative IHC staining of N6AMT1 in eight normal (left) and tumor (right) tissues of the colon (A), liver (B), stomach (C), kidney (D), lung (E), thyroid (F) and endometrium (G).